Teva Delivers Investors Some Rare Good News With Higher Profits Than Expected

A week after its CEO stepped down, drug maker exceeds analysts’ estimates for sales and profits in 2016's fourth quarter.

Yoram Gabison
Yoram Gabison
Yitzhak Peterburg, acting CEO of Teva Pharmaceuticals since Erez Vigodman stepped down from that post in early February, 2017.
Yitzhak Peterburg, acting CEO of Teva Pharmaceuticals since Erez Vigodman stepped down last week.Credit: Jonathan Blum

Comments